| review article | Q7318358 |
| scholarly article | Q13442814 |
| evaluation study | Q58898636 |
| P6179 | Dimensions Publication ID | 1023448353 |
| P356 | DOI | 10.1186/1471-2334-12-103 |
| P932 | PMC publication ID | 3423001 |
| P698 | PubMed publication ID | 22536883 |
| P5875 | ResearchGate publication ID | 224853336 |
| P50 | author | Stephen Lawn | Q28151824 |
| P2860 | cites work | Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance | Q22241307 |
| Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry | Q28269977 | ||
| Rapid molecular detection of tuberculosis and rifampin resistance | Q29617127 | ||
| Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis | Q33498116 | ||
| Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples | Q33547441 | ||
| Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting | Q33625883 | ||
| Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments | Q33754177 | ||
| Roles of lipoarabinomannan in the pathogenesis of tuberculosis | Q33804092 | ||
| Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients | Q33924587 | ||
| Development of antigen detection assay for diagnosis of tuberculosis using sputum samples | Q33967457 | ||
| Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis | Q34046432 | ||
| Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria | Q34173643 | ||
| Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study | Q34185333 | ||
| Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis | Q34198711 | ||
| Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti-lipoarabinomannan detection in pulmonary tuberculosis. | Q51721996 | ||
| Identification and characterization of Mycobacterium tuberculosis antigens in urine of patients with active pulmonary tuberculosis: an innovative and alternative approach of antigen discovery of useful microbial molecules. | Q54422819 | ||
| Detection of Mycobacterium tuberculosis antigens in urinary proteins of tuberculosis patients. | Q54548512 | ||
| Tuberculosis | Q56067169 | ||
| Towards a point-of-care test for active tuberculosis: obstacles and opportunities | Q58484612 | ||
| Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine | Q58863451 | ||
| Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli | Q70302400 | ||
| Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre | Q73855728 | ||
| Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings | Q83397592 | ||
| Epidemiology of HIV-associated tuberculosis | Q34519940 | ||
| Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response | Q34649660 | ||
| Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system | Q35067040 | ||
| Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosis | Q35218926 | ||
| Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis | Q35336481 | ||
| Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration | Q35336560 | ||
| Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens | Q35530503 | ||
| Characteristics and early outcomes of patients with Xpert MTB/RIF-negative pulmonary tuberculosis diagnosed during screening before antiretroviral therapy | Q35845327 | ||
| Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study | Q35859708 | ||
| Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. | Q36027979 | ||
| Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. | Q36825344 | ||
| Detection of lipoarabinomannan as a diagnostic test for tuberculosis | Q37126998 | ||
| Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings | Q37168581 | ||
| Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa | Q37265947 | ||
| Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis. | Q37893820 | ||
| Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis | Q38912905 | ||
| Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. | Q39163332 | ||
| Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy diagnostic yield and association with immune reconstitution disease | Q39163358 | ||
| Low Molecular Weight Proteinuria | Q39597876 | ||
| Sensitivity and specificity of enzyme-linked immunosorbent assay in the detection of antigen in tuberculous meningitis cerebrospinal fluids | Q40205843 | ||
| Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus | Q45382584 | ||
| Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact | Q46456488 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| Mycobacterium tuberculosis | Q130971 | ||
| lipopolysaccharide | Q421804 | ||
| Lipoarabinomannan | Q6556678 | ||
| human immunodeficiency virus infectious disease | Q18556697 | ||
| point-of-care system | Q64733592 | ||
| bacterial antigens | Q65983976 | ||
| bacteriological techniques | Q68756090 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 103 | |
| P577 | publication date | 2012-04-26 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review | |
| P478 | volume | 12 |
| Q59807599 | A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis |
| Q39129290 | A breakthrough urine-based diagnostic test for HIV-associated tuberculosis |
| Q28541690 | A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward? |
| Q90664837 | Accuracy of Two Point-of-Care Tests for Rapid Diagnosis of Bovine Tuberculosis at Animal Level using Non-Invasive Specimens |
| Q36299527 | Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health |
| Q38562541 | Advances in Diagnostic Assays for Tuberculosis |
| Q36833723 | Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test |
| Q39336909 | Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays |
| Q28658322 | Antibodies against Mycobacterial proteins as biomarkers for HIV-associated smear-negative tuberculosis |
| Q38178810 | Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence |
| Q104567206 | Biomarkers as diagnostic tools for mycobacterial infections in cattle |
| Q91641517 | Broad-spectrum capture of clinical pathogens using engineered Fc-mannose-binding lectin enhanced by antibiotic treatment |
| Q48170653 | Calibrant-Free Analyte Quantitation via a Variable Velocity Flow Cell |
| Q34579955 | Can point-of-care urine LAM strip testing for tuberculosis add value to clinical decision making in hospitalised HIV-infected persons? |
| Q38203355 | Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis |
| Q37151512 | Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis |
| Q41923907 | Clinic-Based Urinary Lipoarabinomannan as a Biomarker of Clinical Disease Severity and Mortality Among Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Infected Adults in South Africa |
| Q33820488 | Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals |
| Q34048848 | Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda |
| Q28069032 | Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis |
| Q39414910 | Detection of Lipid and Amphiphilic Biomarkers for Disease Diagnostics |
| Q28073433 | Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis |
| Q26765388 | Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications |
| Q62736121 | Detection of lipoarabinomannan in urine and serum of HIV-positive and HIV-negative TB suspects using an improved capture-enzyme linked immuno absorbent assay and gas chromatography/mass spectrometry |
| Q38376927 | Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering |
| Q60912309 | Detection of the tuberculosis biomarker mannose-capped lipoarabinomannan in human serum: Impact of sample pretreatment with perchloric acid |
| Q34978276 | Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies |
| Q38682808 | Diagnosis of Tuberculosis in HIV Co-infected Individuals: Current Status, Challenges and Opportunities for the Future |
| Q39070206 | Diagnosis of opportunistic infections: HIV co-infections - tuberculosis |
| Q26752536 | Diagnostic 'omics' for active tuberculosis |
| Q94479704 | Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data |
| Q35103208 | Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study |
| Q34098274 | Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults |
| Q35795483 | Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana–findings from the DETECT HIV-TB study |
| Q36315432 | Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort |
| Q64080150 | Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study |
| Q47202823 | Discovery of a unique Mycobacterium tuberculosis protein through proteomic analysis of urine from patients with active tuberculosis. |
| Q55016083 | Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review. |
| Q39346385 | Does disseminated nontuberculous mycobacterial disease cause false-positive Determine B-LAM lateral flow assay results? A retrospective review |
| Q38114142 | Economic evaluations of point of care testing strategies for active tuberculosis |
| Q36408928 | Effect of antiretroviral therapy on the diagnostic accuracy of symptom screening for intensified tuberculosis case finding in a South African HIV clinic |
| Q37413219 | Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival |
| Q35860237 | Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine |
| Q35382585 | Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial |
| Q36856725 | Evaporative concentration on a paper-based device to concentrate analytes in a biological fluid |
| Q58610739 | Exhaled human breath analysis in active pulmonary tuberculosis diagnostics by comprehensive gas chromatography-mass spectrometry and chemometric techniques |
| Q42290950 | Expedient synthesis of the heneicosasaccharyl mannose capped arabinomannan of the Mycobacterium tuberculosis cellular envelope by glycosyl carbonate donors |
| Q38667168 | GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens |
| Q38595689 | Glycan-based diagnostic devices: current progress, challenges and perspectives. |
| Q34509326 | HIV-associated tuberculosis: relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays |
| Q30653441 | Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa |
| Q37255263 | Impact of three empirical anti-tuberculosis treatment strategies for people initiating antiretroviral therapy. |
| Q40416538 | Importance of specimen pretreatment for the low-level detection of mycobacterial lipoarabinomannan in human serum |
| Q91559712 | Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk |
| Q35608544 | In vivo biosynthesis of terpene nucleosides provides unique chemical markers of Mycobacterium tuberculosis infection |
| Q36261370 | Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya |
| Q41585583 | Integrating clinical services for HIV, tuberculosis, and cryptococcal disease in the developing world: a step forward with 2 novel diagnostic tests |
| Q64089805 | Lateral Flow Urine Lipoarabinomannan Assay for Diagnosis of Active Tuberculosis in Adults With Human Immunodeficiency Virus Infection: A Prospective Cohort Study |
| Q24185754 | Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults |
| Q34455442 | Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review |
| Q37469586 | Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV. |
| Q58570772 | Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis |
| Q38556477 | Newer Diagnostic Tests for Pulmonary Tuberculosis in Children |
| Q33994150 | Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B |
| Q36264236 | Performance of point-of-care urine test in diagnosing tuberculosis suspects with and without HIV infection in selected peripheral health settings of Addis Ababa, Ethiopia |
| Q92445238 | Point-Of-Care Urine LAM Tests for Tuberculosis Diagnosis: A Status Update |
| Q37694942 | Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays |
| Q34203557 | Prevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of Congo |
| Q26798435 | Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis |
| Q33975232 | Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis |
| Q26739001 | Pulmonary Tuberculosis Diagnosis: Where We Are? |
| Q36569801 | Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic Region |
| Q35746807 | Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa |
| Q36192057 | Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis |
| Q38178999 | Recent advances in the diagnosis of Mycobacterium tuberculosis. |
| Q37285167 | Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa |
| Q33743476 | Serological diagnostic assays for HIV-associated tuberculosis in sub-Saharan Africa? |
| Q50064564 | Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children |
| Q57689482 | Symptom screening for active tuberculosis in pregnant women living with HIV |
| Q92869661 | Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients |
| Q33666322 | The Diagnostic Value of Urine Lipoarabinomannan (LAM) Antigen in Childhood Tuberculosis |
| Q30357155 | The biology of mycobacterium tuberculosis infection. |
| Q40095857 | The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study |
| Q35961812 | The role of rapid diagnostic tests in managing adults with pneumonia in low-resource settings |
| Q92572130 | Tuberculosis |
| Q36460138 | Tuberculosis Case Finding in HIV-Infected Pregnant Women in Kenya Reveals Poor Performance of Symptom Screening and Rapid Diagnostic Tests |
| Q41922196 | Tuberculosis case finding with combined rapid point of care assays (Xpert® MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique |
| Q35801370 | Underestimation of the True Specificity of the Urine Lipoarabinomannan Point-of-Care Diagnostic Assay for HIV-Associated Tuberculosis |
| Q34085853 | Update on opportunistic infections in the era of effective antiretroviral therapy |
| Q57787695 | Urinary LAM grade, culture positivity, and mortality among HIV-infected South African out-patients |
| Q24187533 | Urine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIV |
| Q90319517 | Urine lipoarabinomannan (LAM) and antimicrobial usage in seriously-ill HIV-infected patients with sputum smear-negative pulmonary tuberculosis |
| Q34660180 | Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study |
| Q33576204 | Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study |
| Q87522060 | Urine lipoarabinomannan testing in children with tuberculosis |
| Q36826688 | Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis |
| Q35079443 | Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis |
| Q34798215 | Video Q&A: rapid urine LAM test for HIV-associated TB--potential to reduce deaths? An interview with Stephen Lawn |
| Q37656864 | When smear and molecular diagnostics fail: identification of tuberculosis in advanced HIV infection using the newly developed urine lipoarabinomannan lateral-flow assay |
Search more.